Official Publication of Houston Methodist DeBakey Heart & Vascular Center
IN THIS ISSUE
Guest Editors Henry Pownall and Antonio Gotto Offer Insight and Expertise on the topic of Lipids and Cardiovascular Disease
See MoreCholesterol: Can’t Live With It, Can’t Live Without It
How Much Do Lipid Guidelines Help the Clinician? Reading Between the (Guide)lines
Statins: Then and Now
Poststatin Lipid Therapeutics: A Review
HDL and Reverse Cholesterol Transport Biomarkers
Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability
High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes
Gene Delivery in Lipid Research and Therapies
Device-Related Thrombus: A Reason for Concern?
Retained Coronary Balloon Requiring Emergent Open Surgical Retrieval: An Uncommon Complication Requiring Individualized Management Strategies
Loperamide Mimicking Brugada Pattern
Reversed Pulsus Paradoxus in Right Ventricular Failure
Transcatheter Embolization of a Persistent Vertical Vein: A Rare Cause of Left-to-Right Shunt and Right-Sided Heart Failure
Addressing the Feedback Loop Between Depression, Diabetes, and Cardiovascular Disease
Addressing the Underrepresentation of Women in Cardiology through Tangible Opportunities for Mentorship and Leadership
Vol 15, Issue 1 (2019)
Showing results for keyword “ SGLT2 inhibitors”
Patricia Mejia Osuna Vol 14, Issue 4
Keywords: heart failure , type 2 diabetes , therapeutic options , DPP-4 inhibitors , GLP-1 agonists , SGLT2 inhibitorsOsuna PM, Brown SJ, Tabatabai LS, Hamilton DJ. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure. Methodist DeBakey Cardiovasc J. 2018;14(4):257-65.
